Oral Surgery for Patients on Anticoagulant Therapy: Current Thoughts on Patient Management

Dental Clinics of North America

Volumn 56, Issue 1, 2012, Pages 25-41

  Doonquah, Ladi ^a,b   Mitchell, Anika D ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

Author keywords

Anticoagulation therapy; Hemostasis; Minor oral surgery

Indexed keywords

ANTICOAGULANT AGENT; HEMOSTATIC AGENT;

BLEEDING; DENTAL PROCEDURE; HEMOSTASIS; HUMAN; METHODOLOGY; MINOR SURGERY; ORAL SURGERY; PATIENT CARE PLANNING; POSTOPERATIVE HEMORRHAGE; REVIEW; RISK FACTOR; THROMBOSIS;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; DENTAL CARE FOR CHRONICALLY ILL; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; ORAL SURGICAL PROCEDURES; PATIENT CARE PLANNING; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; SURGICAL PROCEDURES, MINOR; THROMBOSIS;

EID: 82155170742     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2011.06.002     Document Type: Review

References (65)

1. Nematullah A., Alabousi A., Blanas N., et al. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc 2009, 75(1):41. a-41i.
2. Blinder D., Manor Y., Martinowitz U., et al. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 2001, 30:518.
3. Todd D.W. Anticoagulant therapy: consideration of modification in conjunction with minor surgery. J Oral Maxillofac Surg 2003, 61:1117-1118.
4. Ansell J.E. The perioperative management of warfarin therapy. Arch Intern Med 2003, 163:881-883.
5. Bajkin B.V., Todorovic L.M. Safety of local anaesthesia in dental patients taking oral anticoagulants: is it still controversial?. Br J Oral Maxillofac Surg 2010 Dec 2, 10.1016/j.bjoms.2010.11.002.
6. Al-Mubarak S., Ali N., Rass M., et al. Evaluation of dental extractions, suturing and INR on postoperative bleeding of patients maintained on oral anticoagulant therapy. Br Dent J 2007, 203:E15.
7. Wahl M.J. Dental surgery in anticoagulated patients. Arch Intern Med 1998, 158:1610-1616.
8. Smith N.L., Psaty B.M., Furberg C.D., et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch Intern Med 1999, 159:1574-1578.
9. Ruigómeza A., Johanssonbc S., Wallanderbd M., et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002, 55:358-363.
10. Waldrep A.C., McKelvey L.E. Oral surgery for patients on anticoagulant therapy. J Oral Surg 1968, 26:374-380.
11. Mehta D.K. Dental surgery in the anticoagulated patient. Br Dent J 2003, 194:530.
12. Dunn A.S., Turpie A.G. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003, 163(8):901-908.
13. Thomas S., Katbab H., abu Fanas S.H. Do preoperative cutaneous bleeding time tests predict the outcome of intraoral surgical bleeding?. Int Dent J 2010, 60:305-310.
14. Greenberg M.S., Miller M.F., Lynch M.A. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants. J Am Dent Assoc 1972, 84:583-587.
15. McBane R.D., Felty C.L., Hartgers M.L., et al. Importance of device evaluation for point of care prothrombin time international normalized ratio testing programs. Mayo Clin Proc 2005, 80:181-186.
16. Raber N. Coagulation tests. Clinical methods: the history, physical, and laboratory examinations 1990, 739-742. Butterworths, Boston. 3rd edition. H.K. Walker, W.D. Hall, J.W. Hurst (Eds.).
17. Kuijer P., Hutten B.A., Prins M.H., et al. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 1999, 159:457-460.
18. Lip G.Y., Frison L., Halperin J.L., et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2011, 57:173-180.
19. Pisters R., Lane D.A., Nieuwlaat R., et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. Chest 2010, 138:1093-1100.
20. Berman F. Herb-drug interactions. Lancet 2000, 355:134-138.
21. Mar C., Bent S. An evidence-based review of the 10 most commonly used herbs. West J Med 1999, 17:168-171.
22. Fareed J., Adiguzel C., Thethi I. Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism. Thromb J 2011, 9(1):5. 10.1186/1477-9560-9-5.
23. Hirsh J., Shaughnessy S.G., Halperin J.L., et al. Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001, 119:64S-94S.
24. Bauer K. New anticoagulants. Curr Opin Hematol 2008, 15:509-515.
25. Madan G., Madan S., Madan G., et al. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg 2005, 63:1262-1265.
26. Partridge C.G., Campbell J.H., Alvarado F. The effect of platelet-altering medications on bleeding from minor oral surgery procedures. J Oral Maxillofac Surg 2008, 66:93-97.
27. Krysiak R., Zmuda W., Okopień B. The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol 2011, 10.1111/j.1472-8206.2011.00932.x.
28. Wahl M.J. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 2000, 131:77-81.
29. Hirsh J., Fuster V., Ansel J., et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003, 107:1692-1711.
30. Baglin T.P., Keeling D.M., Watson H.G. Guidelines on oral anticoagulation. Br J Haematol 2006, 132:277-285.
31. Kearon C., Kahn S.R., Agnelli G., et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:454S-545S.
32. Marietta M., Bertesi M., Simoni L., et al. A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery. Clin Lab Haematol 2003, 25:127-130.
33. Milligan P.E., Banet G.A., Gage B.F. Perioperative reduction of the warfarin dose. Am J Med 2003, 115:741-742.
34. Malmquist J.P., Clemens S.C., Oien H.J., et al. Hemostasis of oral surgery wounds with the HemCon dental dressing. J Oral Maxillofac Surg 2008, 66:1177-1183.
35. Todd D.W. Anticoagulated patients and oral surgery. Arch Intern Med 2003, 163:1242.
36. Gibbons A.J., Evans I.L., Sayers M.S., et al. Warfarin and extractions. Br Dent J 2002, 193:302.
37. Gibbons A.J., Sugar A.W. Evidence for continuing warfarin during dental extractions. Br Dent J 2003, 194:65.
38. Balderston R.H. Warfarin and extraction. Br Dent J 2003, 194:408-409.
39. Brown A.E. Warfarin and extractions. Br Dent J 2002, 193:668.
40. Gibbons A.J., Sugar A.W. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2003, 41:280.
41. Ansell J. Issues in thrombosis management and anticoagulation: warfarin versus new agents: interpreting the data. Hematology 2010, 2010:221-228.
42. Johnson-Leong C., Rada R.E. The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy. J Am Dent Assoc 2002, 133:1083-1087.
43. Morimoto Y., Niwa H., Minematsu K. Risk factors affecting postoperative hemorrhage after tooth extraction in patients receiving oral antithrombotic therapy. J Oral Maxillofac Surg 2011, 69:1550-1556.
44. Roser S.M., Rosenbloom B. Continued anticoagulation in oral surgery procedures. Oral Surg Oral Med Oral Pathol 1975, 40:448-457.
45. Aldridge E., Cunningham L.L. Current thoughts on treatment of patients receiving anticoagulation therapy. J Oral Maxillofac Surg 2010, 68:2879-2887.
46. Al-Belasy F.A., Amer M.Z. Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin treated patients undergoing oral surgery. J Oral Maxillofac Surg 2003, 61:1405-1409.
47. Kim J.C., Choi S.S., Wang S.J., et al. Minor complications after mandibular third molar surgery: type, incidence, and possible prevention. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102:4-11.
48. Borea G., Montebugnoli L., Capuzzi P., et al. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1993, 75:29-31.
49. Carter G., Goss A. Tranexamic acid mouthwash-a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 2003, 32:504-507.
50. Sindet-Pedersen S., Ramstrom G., Bernvil S., et al. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989, 320:840-843.
51. Carter G., Goss A., Lloyd J., et al. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extraction: a randomized prospective clinical study. J Oral Maxillofac Surg 2003, 62:1432-1435.
52. Kaewpradub P., Apipan B., Rummasak D. Does tranexamic acid in an irrigating fluid reduce intraoperative blood loss in orthognathic surgery: a double blind randomized clinical trial. J Oral Maxillofac Surg 2011, 69:186-189.
53. Brewer A.K. Advances in minor oral surgery in patients with congenital bleeding disorders. Haemophilia 2008, 14:119-121.
54. Kaddour Brahim A., Stieltjes N., Roussel-Robert V., et al. Dental extractions in children with congenital coagulation disorders: therapeutic protocol and results. Rev Stomatol Chir Maxillofac 2006, 107:331-337.
55. Mokhtari H., Roosendaal G., Koole R., et al. Oral surgery in hemophilia patients. Ned Tijdschr Tandheelkd 2003, 110:74-77.
56. Zanon E., Martinelli F., Bacci C., et al. Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia 2000, 6:533-536.
57. Campbell J.H., Alvarado F., Murray R.A. Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered?. J Oral Maxillofac Surg 2000, 58:131-135.
58. Ward B., Smith M. Dentoalveolar procedures for the anticoagulated patient: literature recommendations versus current practice. J Oral Maxillofac Surg 2007, 65:1454-1460.
59. Carter G., Goss A.N., Lloyd J., et al. Current concepts of the management of dental extractions for patients taking warfarin. Aust Dent J 2003, 48:89-96.
60. Thomas S., Jeske A.H., Suchko G.D. Lack of scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 2003, 134:1492-1497.
61. Lloyd R.E. Dental surgery in the anticoagulated patient. Br Dent J 2003, 194:530.
62. Della Valle A., Sammartino G., Marenzi G., et al. Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel. J Oral Maxillofac Surg 2003, 61:1275-1278.
63. Muthukrishnan A., Bishop K. An assessment of the management of patients on warfarin by general dental practitioners in South West Wales. Br Dent J 2003, 195:567-570.
64. Webster K., Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000, 38:124-126.
65. Muthukrishnan A. Re: Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2002, 40:226.